SCHEMBL1995977

SCHEMBL1995977

CC(C)(C)[C@@]1(C)CN(Cc2ccc(N)cc2C(F)(F)F)CCN1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.55
KDM4E B2RXH2 3/20 0.39
ATM Q13315 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
KIT P10721 4/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
RET P07949 3/20 0.37
BRAF P15056 2/20 0.37
KDR P35968 2/20 0.37
SRC P12931 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
CDK8 P49336 1/20 0.36
EGFR P00533 1/20 0.36
GPR183 P32249 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377502 0.86 NR1H2 (0.36) NR1H2KDM4EATMNPSR1TDP1
SCHEMBL2004447 0.85 KCNJ1 (0.41) NR1H2KDM4EATMNPSR1TDP1
SCHEMBL377823 0.80 LMNA (0.44) KDM4EATMALDH1A1MEN1KMT2A
SCHEMBL377467 0.80 LMNA (0.44) KDM4EATMALDH1A1MEN1KMT2A
SCHEMBL2708121 0.77 NR1H2 (0.67) NR1H2KDM4EATMNPSR1TDP1
SCHEMBL2003107 0.75 MLNR (0.47) KDM4EKITRETBRAFKDR
SCHEMBL23068663 0.74 NR1H2 (0.70) NR1H2KDM4EATMNPSR1TDP1
SCHEMBL377621 0.74 CNR2 (0.36) KDM4EATMNPSR1TDP1ALDH1A1
SCHEMBL2853512 0.73 NR1H2 (0.58) NR1H2KDM4EATMNPSR1TDP1
SCHEMBL27088086 0.73 NR1H2 (0.60) NR1H2KDM4EATMNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964597-B2 Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases GLAXO GROUP LIMITED (GB) 2011-06-21 US disclosed
EP-2212299-A1 PIPERAZINYL-SULFONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES Glaxo Group Limited (GB) 2010-08-04 EP disclosed
WO-2009068552-A1 PIPERAZINYL-SULFONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF GPR38 RECEPTOR MEDIATED DISEASES GLAXO GROUP LIMITED (GB) 2009-06-04 WO disclosed